MML Investors Services LLC Sells 351 Shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE)

MML Investors Services LLC decreased its stake in shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) by 8.8% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 3,621 shares of the company’s stock after selling 351 shares during the quarter. MML Investors Services LLC owned 0.09% of Invesco Biotechnology & Genome ETF worth $253,000 as of its most recent filing with the SEC.

A number of other large investors have also made changes to their positions in the stock. UMB Bank n.a. bought a new stake in shares of Invesco Biotechnology & Genome ETF during the second quarter valued at approximately $31,000. Massachusetts Wealth Management boosted its stake in Invesco Biotechnology & Genome ETF by 15.3% during the second quarter. Massachusetts Wealth Management now owns 16,944 shares of the company’s stock worth $1,098,000 after buying an additional 2,245 shares in the last quarter. Ashton Thomas Private Wealth LLC bought a new stake in Invesco Biotechnology & Genome ETF in the 2nd quarter valued at $26,000. One Capital Management LLC raised its stake in shares of Invesco Biotechnology & Genome ETF by 31.9% in the 2nd quarter. One Capital Management LLC now owns 25,402 shares of the company’s stock valued at $1,646,000 after buying an additional 6,137 shares in the last quarter. Finally, Cetera Investment Advisers lifted its holdings in shares of Invesco Biotechnology & Genome ETF by 2.1% during the 2nd quarter. Cetera Investment Advisers now owns 27,893 shares of the company’s stock worth $1,808,000 after acquiring an additional 561 shares during the period.

Invesco Biotechnology & Genome ETF Stock Performance

Shares of Invesco Biotechnology & Genome ETF stock opened at $67.46 on Thursday. The firm has a market cap of $272.54 million, a P/E ratio of 17.12 and a beta of 0.88. The firm’s 50-day simple moving average is $69.09 and its 200-day simple moving average is $68.66. Invesco Biotechnology & Genome ETF has a twelve month low of $59.32 and a twelve month high of $72.84.

About Invesco Biotechnology & Genome ETF

PowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies.